SLC7A5 and lung carcinoma: Taken together, our results demonstrate that FBW7 functions alongside GSK3β to promote IGF2BP2 degradation, thus inhibiting the IGF2BP2-SLC7A5 feedback loop and impairing lung cancer radioresistance (Fig. 7G).